Axsome Therapeutics (NASDAQ:AXSM) Sets New 52-Week High Following Analyst Upgrade
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) shares hit a new 52-week high during mid-day trading on Tuesday after Bank of America raised their price target on the stock from $143.00 to $167.00. Bank of America currently has a buy rating on the stock. Axsome Therapeutics traded as high as $132.25 and last traded […]
Axsome Therapeutics, Inc. (NASDAQ:AXSM – Get Free Report) shares hit a new 52-week high during mid-day trading on Tuesday after Bank of America raised their price target on the stock from $143.00 to $167.00. Bank of America currently has a buy rating on the stock. Axsome Therapeutics traded as high as $132.25 and last traded […]
